learningcurve2020,
Pre revenue companies lose money. Many small businesses lose money for the first 3 years while spending on customer acquisition and overhead. Biotechs very typically spend over $1,000,000,000 getting just a single indication drug to market and immunotherapies have taken 10-20+ years on average to develop to the point of marketing. NWBO has spent somewhat more than this while developing an entire platform technology by starting with a single indication Phase 3 trial that has the potential as a platform to treat about 85% of all diseases. Not only this but they developed de novo commercial scale manufacturing along with it. Glad you can see that losses are and have been expected as part of this sector and will be for NWBO up until their commercial phase of operations.
Looking at that ongoing concern mention you should note that it has been on the books each and every year I have been invested and that includes from prices of $.14 to $12.54. Funny that this ongoing concern statement somehow becomes so much more important to you now when they are closer to approval and worldwide commercial manufacturing scalability than ever before; ). Your intentions are obvious and totally ineffective against the vote for management support. You must be steamed!; ).
So 2020 was “magical” because the lifetime double bottom was called on this board and since you are so concerned with investors here making money then that would have been the time to back up the truck so to speak. I don’t recall you ever suggesting that you were doing so or that you thought it might be a good time for others to. Since you identify yourself as a trader and seem to want to compare your calls to mine where was your call back then?; ). If you recall Mr. Neil Woodford’s funds had finished divesting and progress was being made to work towards data lock. Yep, that was a “magical” year and one in which I loaded up as I also did in 2017. If that is brainy then I’m laughing with you all the way to the bank. If you recall exwannabe was honest enough to admit that he missed out on that potential 10X+ trade and I never saw a boast from you about one with NWBO either.
My strategy is not a trading strategy with accumulation, just accumulation itself until the target is hit or the stock gets passed on with a target for others in mind. My success with this strategy will not be determined fully until a later date. For now, I’m still in the black with all my accounts and ready for any more foolishness the market wants to tolerate with regard to this share price; ).
As regards Mr. Buffet, he has seen what happens to those who mess with Linda. He’ll wait for the manufacturing with Flaskworks to pass muster and a different exchange to trade on just like other institutions will. He can then chose to either invest in NWBO directly or in others who will connect themselves to them that he likely is already invested in. Feel free to bookmark this post and check back in about 2 years when Flaskworks is fully ramping ; ). Best wishes.
AI
Market Data 
Markets 
